Send to

Choose Destination
Nat Rev Genet. 2007 Aug;8(8):573-87. Epub 2007 Jul 3.

Engineering targeted viral vectors for gene therapy.

Author information

Division of Human Gene Therapy, 502 Biomedical Research Building II, 901 19th Street, South Birmingham, Alabama 35294-2172, USA.


To achieve therapeutic success, transfer vehicles for gene therapy must be capable of transducing target cells while avoiding impact on non-target cells. Despite the high transduction efficiency of viral vectors, their tropism frequently does not match the therapeutic need. In the past, this lack of appropriate targeting allowed only partial exploitation of the great potential of gene therapy. Substantial progress in modifying viral vectors using diverse techniques now allows targeting to many cell types in vitro. Although important challenges remain for in vivo applications, the first clinical trials with targeted vectors have already begun to take place.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center